General

UK approves first Alzheimer drug for early use

The Medicines and Healthcare products Regulatory Agency (MHRA) approved on Thursday, a product license for the medicine lecanemab for use in the early stages of Alzheimer’s, after proving that it slow the progression of disease by 27 percent.

The

ABOUT us
Welcome to Lebanon News Gazette, your window into the captivating world of Lebanese news and beyond. We are here to deliver timely, accurate, and captivating coverage that keeps you informed and engaged.